COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,606 | -79.9% | 22,087 | -77.1% | 0.00% | -81.2% |
| Q2 2023 | $411,995 | +332.5% | 96,486 | +592.8% | 0.02% | +300.0% |
| Q1 2023 | $95,254 | -72.5% | 13,926 | -70.9% | 0.00% | -73.3% |
| Q2 2022 | $346,000 | +25.8% | 47,801 | +179.1% | 0.02% | -25.0% |
| Q3 2021 | $275,000 | -16.9% | 17,127 | -28.3% | 0.02% | -37.5% |
| Q2 2021 | $331,000 | – | 23,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |